Randomized Controlled Trial to Evaluate the Impact of ZYN Nicotine Pouch Products on Cigarette Usage and BoExp in Adult Smokers Over a 12-week Period

NCT ID: NCT06568900

Last Updated: 2024-08-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-31

Study Completion Date

2024-08-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To verify whether unrestricted access to flavored products is likely to lead to greater reductions in combustible cigarette smoking and decreased exposure to smoking related toxicants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

US adult smokers will be randomized into three groups (Group I: (control) continue smoking their usual brand of CC; Group II: provided with tobacco flavor and unflavored options of ZYN; Group III: provide with unrestricted flavor options of ZYN) to evaluate the impact of availability of different ZYN products on cigarette usage patterns and biomarkers of exposure over a 12-week study period, followed by an 6-week extension for some participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

(control) continue smoking their usual brand of CC

Group Type ACTIVE_COMPARATOR

cigarette smoking

Intervention Type OTHER

continue smoking usual brand of cigarette

tobacco flavor and unflavored options of ZYN

Group Type ACTIVE_COMPARATOR

tobacco flavored and unflavored pouch

Intervention Type OTHER

provide tobacco flavored and unflavored options of nicotine pouch

unrestricted flavor options of ZYN

Group Type ACTIVE_COMPARATOR

unrestricted flavor options pouch

Intervention Type OTHER

provide unrestricted flavor options of nicotine pouch

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cigarette smoking

continue smoking usual brand of cigarette

Intervention Type OTHER

tobacco flavored and unflavored pouch

provide tobacco flavored and unflavored options of nicotine pouch

Intervention Type OTHER

unrestricted flavor options pouch

provide unrestricted flavor options of nicotine pouch

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy adult smokers 22 to 65 years of age (inclusive) at screening.
* Smokes an average of at least 10 commercially available cigarettes per day for the last 12 months.
* Interested in switching from combustible cigarettes to nicotine pouch products.

Exclusion Criteria

* Participants of childbearing potential (CBP) who are breast-feeding or have a positive pregnancy test.
* Participants who currently use nicotine pouches.
* Participants with known heart disease or medical condition that may adversely affect participant safety
Minimum Eligible Age

22 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swedish Match AB

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brian E Erkkila, PhD

Role: STUDY_CHAIR

Swedish Match

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rose Research Center

Raleigh, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00070188

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute Effects of Oral Nicotine Pouches
NCT07128329 RECRUITING PHASE1
The Options 2 Study
NCT06595459 RECRUITING PHASE4